Literature DB >> 12756085

Alternative therapies for localized prostate cancer.

Harrie P Beerlage1.   

Abstract

Prostate cancer is the leading malignancy in men; an increase in detected localized prostate cancers is expected in the years to come. Radical prostatectomy, although effective, is associated with a considerable morbidity. The aim of minimal invasive alternative treatment options should be equal efficacy, but a decrease in side effects. Cryosurgical ablation of the prostate, brachytherapy, high-intensity focused ultrasound, and radiofrequency interstitial tumor ablation were evaluated after a literature review from a MEDLINE search (1966-2002). When compared with treatments in the 1960s and 1970s, increased safety is observed in all of the alternative treatments available today. Sophisticated technology, including the latest ultrasonography devices for exact planning and monitoring of treatment, contributes largely to this safety. Five-year results of cryosurgical ablation of the prostate show a prostate-specific antigen lower than 1 ng/mL in 60% of the cases; in the third generation, there are no long-term data available on cryosurgical ablation of the prostate. Recent outcome data of brachytherapy come close to results of radical prostatectomy series. Brachytherapy is the only true alternative at this point in time. High-intensity focused ultrasound and radiofrequency interstitial tumor ablation are promising new technologies that have proven to be able to induce extensive necrosis; however, follow-up is too short to determine their definite places in the treatment of prostate cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12756085     DOI: 10.1007/s11934-003-0072-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  50 in total

1.  High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.

Authors:  H P Beerlage; G J van Leenders; G O Oosterhof; J A Witjes; E T Ruijter; C A van de Kaa; F M Debruyne; J J de la Rosette
Journal:  Prostate       Date:  1999-04-01       Impact factor: 4.104

2.  Iridium-192 brachytherapy in the treatment of cancer of the prostate.

Authors:  B J Donnelly; J E Pedersen; A T Porter; M S McPhee
Journal:  Urol Clin North Am       Date:  1991-08       Impact factor: 2.241

3.  Cryosurgery as a treatment for prostate carcinoma: results and complications.

Authors:  W S Wong; D O Chinn; M Chinn; J Chinn; W L Tom; W L Tom
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

4.  Dose-rate effects in synchronous mammalian cells in culture. II. A comparison of the life cycle of HeLa cells during continuous irradiation or multiple-dose fractionation.

Authors:  J B Mitchell; J S Bedford
Journal:  Radiat Res       Date:  1977-09       Impact factor: 2.841

Review 5.  Interstitial implantation techniques in prostate cancer.

Authors:  J Sylvester; J C Blasko; P Grimm; H Ragde
Journal:  J Surg Oncol       Date:  1997-09       Impact factor: 3.454

6.  Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results.

Authors:  A Zisman; A J Pantuck; J K Cohen; A S Belldegrun
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

7.  A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation.

Authors:  R G Stock; N N Stone; M F Wesson; J K DeWyngaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-04-30       Impact factor: 7.038

8.  Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993).

Authors:  F J Fowler; M J Barry; G Lu-Yao; A Roman; J Wasson; J E Wennberg
Journal:  Urology       Date:  1993-12       Impact factor: 2.649

9.  Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.

Authors:  R G Stock; N N Stone; J K DeWyngaert; P Lavagnini; P D Unger
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

10.  Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.

Authors:  J K Cohen; R J Miller; G M Rooker; B A Shuman
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

View more
  3 in total

1.  Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.

Authors:  Zheng Huang; Masoom A Haider; Susan Kraft; Qun Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2006-08       Impact factor: 4.025

2.  The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach.

Authors:  B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

Review 3.  Primary cryotherapy for localised or locally advanced prostate cancer.

Authors:  Jae Hung Jung; Michael C Risk; Robert Goldfarb; Balaji Reddy; Bernadette Coles; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.